PL2411376T3 - Inhibitory nf-kb - Google Patents
Inhibitory nf-kbInfo
- Publication number
- PL2411376T3 PL2411376T3 PL10724601T PL10724601T PL2411376T3 PL 2411376 T3 PL2411376 T3 PL 2411376T3 PL 10724601 T PL10724601 T PL 10724601T PL 10724601 T PL10724601 T PL 10724601T PL 2411376 T3 PL2411376 T3 PL 2411376T3
- Authority
- PL
- Poland
- Prior art keywords
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- AIDS & HIV (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16425609P | 2009-03-27 | 2009-03-27 | |
| US25509609P | 2009-10-27 | 2009-10-27 | |
| US26502609P | 2009-11-30 | 2009-11-30 | |
| EP20100724601 EP2411376B1 (en) | 2009-03-27 | 2010-03-25 | Inhibitors of nf-kb |
| PCT/US2010/028610 WO2010111460A1 (en) | 2009-03-27 | 2010-03-25 | Inhibitors of nf-kb |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2411376T3 true PL2411376T3 (pl) | 2015-10-30 |
Family
ID=42324526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10724601T PL2411376T3 (pl) | 2009-03-27 | 2010-03-25 | Inhibitory nf-kb |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8629164B2 (pl) |
| EP (1) | EP2411376B1 (pl) |
| JP (1) | JP5719344B2 (pl) |
| CN (1) | CN102414190B (pl) |
| CA (1) | CA2755910C (pl) |
| DK (1) | DK2411376T3 (pl) |
| ES (1) | ES2540351T3 (pl) |
| HR (1) | HRP20150777T1 (pl) |
| PL (1) | PL2411376T3 (pl) |
| PT (1) | PT2411376E (pl) |
| SI (1) | SI2411376T1 (pl) |
| SM (1) | SMT201500178B (pl) |
| TW (1) | TW201038561A (pl) |
| WO (1) | WO2010111460A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140380387A1 (en) * | 2011-12-12 | 2014-12-25 | Samsung Electronics Co., Ltd. | System, apparatus and method for utilizing a multimedia service |
| CN103961687A (zh) * | 2013-02-05 | 2014-08-06 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | G蛋白偶联受体相互作用蛋白2在制备抗炎症药物中的应用 |
| CN106645457B (zh) * | 2016-10-13 | 2019-03-15 | 深圳万和制药有限公司 | 水杨酸酰胺衍生物dhmeq软膏剂组合物及分析方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001012588A1 (fr) | 1999-08-11 | 2001-02-22 | Mercian Corporation | Derives de salicylamide |
| JP2002193938A (ja) * | 2000-12-01 | 2002-07-10 | Bayer Ag | ４−アリールピリジン誘導体 |
| WO2004002465A1 (ja) | 2002-06-26 | 2004-01-08 | Signal Creation Inc. | NF-κB阻害剤を含む医薬組成物 |
| EP1600445A4 (en) * | 2003-02-14 | 2008-06-11 | Signal Creation Inc | CURATIVE PREPARATION |
| CN1774429A (zh) * | 2003-02-14 | 2006-05-17 | 学校法人庆应义塾 | 医药组合物 |
| JP2008259494A (ja) | 2007-03-05 | 2008-10-30 | Keio Gijuku | （±）−ｄｈｍｅｑの酵素光学分割法および（−）−ｄｈｍｅｑの製造方法 |
| WO2010127058A1 (en) | 2009-05-01 | 2010-11-04 | Profectus Biosciences, Inc. | Benzamide and naphthamide derivatives inhibiting nuclear factor- kap pa (b) - (nf-kb) |
| EP2443103A1 (en) | 2009-06-18 | 2012-04-25 | Profectus Biosciences, Inc. | Oxabicyclo [4.1.o]hept-b-en-s-ylcarbamoyl derivatives inhibiting the nuclear factor-kappa(b) - (nf-kb) |
-
2010
- 2010-03-25 US US13/258,512 patent/US8629164B2/en not_active Expired - Fee Related
- 2010-03-25 PL PL10724601T patent/PL2411376T3/pl unknown
- 2010-03-25 PT PT107246019T patent/PT2411376E/pt unknown
- 2010-03-25 EP EP20100724601 patent/EP2411376B1/en active Active
- 2010-03-25 CA CA2755910A patent/CA2755910C/en not_active Expired - Fee Related
- 2010-03-25 WO PCT/US2010/028610 patent/WO2010111460A1/en active Application Filing
- 2010-03-25 JP JP2012502229A patent/JP5719344B2/ja not_active Expired - Fee Related
- 2010-03-25 ES ES10724601.9T patent/ES2540351T3/es active Active
- 2010-03-25 DK DK10724601.9T patent/DK2411376T3/en active
- 2010-03-25 CN CN201080020009.9A patent/CN102414190B/zh active Active
- 2010-03-25 SI SI201030979T patent/SI2411376T1/sl unknown
- 2010-03-26 TW TW099109323A patent/TW201038561A/zh unknown
-
2015
- 2015-07-15 HR HRP20150777TT patent/HRP20150777T1/hr unknown
- 2015-07-24 SM SM201500178T patent/SMT201500178B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SMT201500178B (it) | 2015-09-07 |
| CN102414190B (zh) | 2015-06-03 |
| EP2411376B1 (en) | 2015-04-22 |
| CN102414190A (zh) | 2012-04-11 |
| WO2010111460A1 (en) | 2010-09-30 |
| TW201038561A (en) | 2010-11-01 |
| JP2012521998A (ja) | 2012-09-20 |
| EP2411376A1 (en) | 2012-02-01 |
| SI2411376T1 (sl) | 2015-10-30 |
| US8629164B2 (en) | 2014-01-14 |
| US20120015952A1 (en) | 2012-01-19 |
| ES2540351T3 (es) | 2015-07-09 |
| DK2411376T3 (en) | 2015-07-06 |
| CA2755910C (en) | 2016-11-01 |
| PT2411376E (pt) | 2015-09-14 |
| JP5719344B2 (ja) | 2015-05-20 |
| HRP20150777T1 (hr) | 2015-09-11 |
| CA2755910A1 (en) | 2010-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2440054A4 (en) | PYRIDILTRIA INHIBITOR OF HEDGEHOG SIGNALING | |
| EP2424873A4 (en) | NEW GALACTOSID INHIBITORS OF GALECTINES | |
| EP2318395A4 (en) | IPA INHIBITORS | |
| HK1156306A1 (en) | Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases hif--4- | |
| IL218018A0 (en) | Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions | |
| EP2389068A4 (en) | HEMGE OF THE HEDGEHOG SIGNAL PATH | |
| ZA201206456B (en) | Uses of dgati inhibitors | |
| ZA201102604B (en) | Alkylcyclohexylethers of dihydrotetraazabenzoazulenes | |
| EP2519508A4 (en) | METALLO ENZYME INHIBITOR COMPOUNDS | |
| IL220187A0 (en) | Inhibitors of sphingosine kinase | |
| EP2413941A4 (en) | INHIBITORS OF THE RENIN | |
| PT2506840T (pt) | Utilizações de inibidores de fatores induzíveis de hipoxia | |
| EP2521451A4 (en) | INHIBITORS OF THE HEDGEHOG PATH | |
| ZA201004765B (en) | Inhibitors of iap | |
| GB0901898D0 (en) | Dual calpain-ros inhibitors | |
| EP2496230A4 (en) | INHIBITORS OF IRE-1 ALPHA | |
| EP2467385A4 (en) | INHIBITORS OF REINE | |
| IL217756A0 (en) | Inhibitors of jnk | |
| SMT201500178B (it) | Inibitori di nf-kb | |
| EP2501803A4 (en) | PROCESS FOR PLURIPOTENZINTENSIVATION | |
| GB0916010D0 (en) | JMJD2 demethylase inhibitors | |
| GB0901900D0 (en) | Dual calpain-ros inhibitors | |
| IL215486A0 (en) | Compositions of cholinesterase inhibitors | |
| GB0908609D0 (en) | New use of isoQC inhibitors | |
| GB0903650D0 (en) | Glyoalase inhibitors |